SCHEMBL3576015

SCHEMBL3576015

O=S(=O)(O)N1CCC(O)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.35
KCNH2 Q12809 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
TDO2 P48775 2/20 0.33
AKR1C3 P42330 2/20 0.33
HSD11B1 P28845 1/20 0.33
CNR2 P34972 1/20 0.33
BRD4 O60885 1/20 0.33
MAPK1 P28482 1/20 0.33
ATM Q13315 1/20 0.33
TSHR P16473 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GPR119 Q8TDV5 1/20 0.31
LMNA P02545 1/20 0.31
CYP3A4 P08684 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
NFKB1 P19838 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5828751 1.00 TP53 (0.35) TP53KCNH2HRH3TDO2AKR1C3
SCHEMBL3576010 1.00 TP53 (0.35) TP53KCNH2HRH3TDO2AKR1C3
SCHEMBL25726188 0.87 HSD11B1 (0.38) TP53HSD11B1MAPK1ATMTSHR
SCHEMBL3313080 0.83 TP53 (0.47) TP53KCNH2HRH3HSD11B1MAPK1
SCHEMBL27210211 0.83 CA1 (0.39) TP53KCNH2HRH3TDO2AKR1C3
SCHEMBL10317172 0.83 CA1 (0.39) TP53KCNH2HRH3TDO2AKR1C3
SCHEMBL27210217 0.83 CA1 (0.39) TP53KCNH2HRH3TDO2AKR1C3
SCHEMBL16896689 0.83 TP53 (0.47) TP53KCNH2HRH3HSD11B1MAPK1
SCHEMBL16896711 0.83 TP53 (0.47) TP53KCNH2HRH3HSD11B1MAPK1
SCHEMBL5828658 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674810-B2 1,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymerase ROCHE PALO ALTO LLC (US) 2010-03-09 US claimed
CN-101189230-A Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (CH) 2008-05-28 CN claimed
US-20060252785-A1 Heterocyclic antiviral compounds ROCHE PALO ALTO LLC 2006-11-09 US claimed
US-7674810-B2 1,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymerase ROCHE PALO ALTO LLC (US) 2010-03-09 US disclosed
CN-101189230-A Heterocyclic antiviral compounds ROCHE PALO ALTO LLC (CH) 2008-05-28 CN disclosed
US-20060252785-A1 Heterocyclic antiviral compounds ROCHE PALO ALTO LLC 2006-11-09 US disclosed
US-7101895-B2 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors MERCK SHARP & DOHME LIMITED (GB) 2006-09-05 US disclosed
US-20040122050-A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors MERCK SHARP & DOHME LTD. (GB) 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122050-A1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors BACE1, BACE2, APP TP53 2166/4885KCNH2 3504/4885HRH3 1914/4885
US-20060252785-A1 Heterocyclic antiviral compounds EIF2AK2, HAVCR2, POLR2E TP53 1114/4885KCNH2 3756/4885HRH3 3190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.